Impact of POR*28 on the Clinical Pharmacokinetics of CYP3A Phenotyping Probes Midazolam and Erythromycin

Elens, Laure

Impact of POR*28 on the Clinical Pharmacokinetics of CYP3A Phenotyping Probes Midazolam and Erythromycin

(2013) 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology — Location: Salt Lake City, USA (22.September.2013)

Files

No attached file found for this publication.

Details

Authors

Elens, LaureUCLouvain
Author

Affiliations

UCLouvainSSS/LDRI - Louvain Drug Research Institute

Citations

APA
Chicago
FWB

Elens, L. (2013). Impact of POR*28 on the Clinical Pharmacokinetics of CYP3A Phenotyping Probes Midazolam and Erythromycin. Therapeutic Drug Monitoring, 35(5), 686. https://hdl.handle.net/2078.5/190897 (Original work published 2013)